Spring til hovednavigation
Spring til søgning
Spring til hovedindhold
Sorter
Keyphrases
Population-based
100%
Prostate Cancer
100%
European Association of Urology
100%
Prostate-specific Antigen Testing
100%
Structured Populations
100%
Cancer Mortality
75%
Overtreatment
75%
Family History
50%
Prostate-specific Antigen
50%
Total Prostate-specific Antigen
50%
Radical Treatment
50%
Low Risk
25%
Risk Reduction
25%
Breast Cancer
25%
Risk Stratification
25%
Europe
25%
Oncological Outcomes
25%
Mortality Risk
25%
Early Detection
25%
Magnetic Resonance Imaging Scan
25%
Non-selective
25%
Novel Biomarkers
25%
Natural History
25%
Colon Cancer
25%
Locally Advanced
25%
Active Surveillance
25%
Prostate Cancer Risk
25%
In Cancer
25%
Combined Modality Therapy
25%
Prostate Volume
25%
Triage
25%
Cancer Causes
25%
Informed Patient
25%
Intermediate Risk
25%
Population Level
25%
Support Measures
25%
Life Expectancy
25%
Prostate Cancer Screening
25%
Blood Test
25%
Risk Calculator
25%
Prostate-specific Antigen Level
25%
Aggressive Prostate Cancer
25%
Digital Rectal Examination
25%
High-grade Cancer
25%
Stratified Approach
25%
Screening Interval
25%
Personalized Risk
25%
Multiparametric Magnetic Resonance Imaging (mpMRI)
25%
Resonance Risk
25%
Prostate-specific Antigen/blood
25%
Medicine and Dentistry
Prostate Cancer
100%
Prostate Specific Antigen
100%
Urology
100%
Cancer Mortality
42%
Overdiagnosis
42%
Family History
28%
Biopsy Technique
28%
Malignant Neoplasm
14%
Biological Marker
14%
Cancer
14%
Magnetic Resonance Imaging
14%
Colon Carcinoma
14%
Triage
14%
Life Expectancy
14%
Breast Cancer
14%
Cancer Diagnosis
14%
Digital Rectal Examination
14%
Multiparametric Magnetic Resonance Imaging
14%
Cancer Grading
14%
Diseases
14%
Specific Mortality
14%